Fractional Amplitude of Low-frequency Fluctuations in Right Dorsal Cingulum Bundle Associated with Depression Symptoms in AD Patients: Effects of Donepezil Intervention

Overview

Journal Neurol Sci

Specialty Neurology

Date 2024 Dec 9

PMID 39652166

Authors

Zhongwei Guo

Fuquan Wei

Hongtao Hou

Xiaozheng Liu

Affiliations

Soon will be listed here.

Abstract

Objectives: Our aim was to investigate the mechanisms of spontaneous brain activity of white matter functional signals in Alzheimer's disease (AD) patients after donepezil intervention.

Methods: We used resting-state functional magnetic resonance imaging and the fractional amplitude of low-frequency fluctuations (fALFF) approach to investigate changes in spontaneous brain activity of white matter functional signals in AD patients before and after donepezil intervention. A total of 32 subjects participated in the study, including 16 healthy subjects (HCs) and 16 AD patients. The 16 AD patients underwent brain imaging and neuropsychological assessment before and after donepezil. ANOVA and post hoc t-test analysis were used to compare the differences in fALFF between the three groups. Pearson correlations were used to investigate the relationships between abnormal fALFF values and clinical variables in AD patients before and after intervention (P < 0.05).

Results: Compared to HCs, AD patients before donepezil intervention had an abnormal fALFF in superior longitudinal fasciculus 2; AD patients after donepezil intervention had an abnormal fALFF in right superior longitudinal fasciculus 1,2 and right dorsal cingulum, Compared with baseline, AD patients after donepezil intervention had an abnormal fALFF in the right dorsal cingulum. Compared with the baseline, AD patients after donepezil intervention had significantly decreased depression scores (P < 0.0003).

Conclusions: Our study showed that spontaneous activity of functional signalling in the cholinergic pathway was altered in AD patients after donepezil intervention and that this change was associated with depressive symptoms in AD patients.

References

Renn B, Asghar-Ali A, Thielke S, Catic A, Martini S, Mitchell B . A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia. Am J Geriatr Psychiatry. 2017; 26(2):134-147. PMC: 5817050. DOI: 10.1016/j.jagp.2017.09.027. View

Sheikh M, Ammar M . Efficacy of 5 and 10 mg donepezil in improving cognitive function in patients with dementia: a systematic review and meta-analysis. Front Neurosci. 2024; 18:1398952. PMC: 11298496. DOI: 10.3389/fnins.2024.1398952. View

Fan F, Liu H, Shi X, Ai Y, Liu Q, Cheng Y . The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review. J Alzheimers Dis. 2021; 85(3):1195-1204. DOI: 10.3233/JAD-215423. View

Saykin A, Wishart H, Rabin L, Flashman L, McHugh T, Mamourian A . Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain. 2004; 127(Pt 7):1574-83. DOI: 10.1093/brain/awh177. View

Dubois B, Chupin M, Hampel H, Lista S, Cavedo E, Croisile B . Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease. Alzheimers Dement. 2015; 11(9):1041-9. DOI: 10.1016/j.jalz.2014.10.003. View

Griffanti L, Wilcock G, Voets N, Bonifacio G, Mackay C, Jenkinson M . Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study. Dement Geriatr Cogn Dis Extra. 2016; 6(3):518-528. PMC: 5123022. DOI: 10.1159/000450546. View

Zhan Y, Fu Q, Pei J, Fan M, Yu Q, Guo M . Modulation of Brain Activity and Functional Connectivity by Acupuncture Combined With Donepezil on Mild-to-Moderate Alzheimer's Disease: A Neuroimaging Pilot Study. Front Neurol. 2022; 13:912923. PMC: 9309357. DOI: 10.3389/fneur.2022.912923. View

Perini G, Ramusino M, Sinforiani E, Bernini S, Petrachi R, Costa A . Cognitive impairment in depression: recent advances and novel treatments. Neuropsychiatr Dis Treat. 2019; 15:1249-1258. PMC: 6520478. DOI: 10.2147/NDT.S199746. View

Livingston G, Huntley J, Liu K, Costafreda S, Selbaek G, Alladi S . Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024; 404(10452):572-628. DOI: 10.1016/S0140-6736(24)01296-0. View

10.

Deckersbach T, Dougherty D, Rauch S . Functional imaging of mood and anxiety disorders. J Neuroimaging. 2006; 16(1):1-10. DOI: 10.1177/1051228405001474. View

11.

Gao Y, Sengupta A, Li M, Zu Z, Rogers B, Anderson A . Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease. PLoS One. 2020; 15(10):e0240513. PMC: 7567362. DOI: 10.1371/journal.pone.0240513. View

12.

Li J, Chen H, Fan F, Qiu J, Du L, Xiao J . White-matter functional topology: a neuromarker for classification and prediction in unmedicated depression. Transl Psychiatry. 2020; 10(1):365. PMC: 7603321. DOI: 10.1038/s41398-020-01053-4. View

13.

Zhao Y, Zhang F, Zhang W, Chen L, Chen Z, Lui S . Decoupling of Gray and White Matter Functional Networks in Medication-Naïve Patients With Major Depressive Disorder. J Magn Reson Imaging. 2020; 53(3):742-752. DOI: 10.1002/jmri.27392. View

14.

McKhann G, Knopman D, Chertkow H, Hyman B, Jack Jr C, Kawas C . The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):263-9. PMC: 3312024. DOI: 10.1016/j.jalz.2011.03.005. View

15.

Alexopoulos G, ABRAMS R, Young R, SHAMOIAN C . Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988; 23(3):271-84. DOI: 10.1016/0006-3223(88)90038-8. View

16.

Cummings J, Mega M, Gray K, Carusi D, Gornbein J . The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994; 44(12):2308-14. DOI: 10.1212/wnl.44.12.2308. View

17.

Schneider L, Tariot P, Lyketsos C, Dagerman K, Davis K, Davis S . National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry. 2001; 9(4):346-60. View

18.

Peer M, Nitzan M, Bick A, Levin N, Arzy S . Evidence for Functional Networks within the Human Brain's White Matter. J Neurosci. 2017; 37(27):6394-6407. PMC: 6596606. DOI: 10.1523/JNEUROSCI.3872-16.2017. View

19.

Zhang N, Gordon M . Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients. Clin Interv Aging. 2018; 13:1963-1970. PMC: 6187917. DOI: 10.2147/CIA.S159920. View

20.

Mayo C, Mazerolle E, Ritchie L, Fisk J, Gawryluk J . Longitudinal changes in microstructural white matter metrics in Alzheimer's disease. Neuroimage Clin. 2017; 13:330-338. PMC: 5200876. DOI: 10.1016/j.nicl.2016.12.012. View